Less is more: hematologic safety and sustained efficacy of a modified low‐dose etoposide regimen in macrophage activation syndrome

Disclosureform Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.